David Edward Tomaszek, MD | |
111 Vision Park Blvd, Suite 250, Conroe, TX 77384-3002 | |
(936) 321-1130 | |
(936) 321-1230 |
Full Name | David Edward Tomaszek |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 111 Vision Park Blvd, Conroe, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780609768 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | K9191 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
David Edward Tomaszek, MD 111 Vision Park Blvd, Suite 250, Conroe, TX 77384-3002 Ph: (936) 321-1130 | David Edward Tomaszek, MD 111 Vision Park Blvd, Suite 250, Conroe, TX 77384-3002 Ph: (936) 321-1130 |
News Archive
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today signed a Business Cooperation Agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc. ("Celltrion"), which outlines the business terms of a future distribution agreement for the United States, Europe, Australia, New Zealand and Canada for eight biogeneric products that are currently under development by Celltrion, five of which are incremental to Hospira's pipeline.
A research team at the National Institute of Standards and Technology (NIST) studying sugar-coated nanoparticles for use as a possible cancer therapy has uncovered a delicate balancing act that makes the particles more effective than conventional thinking says they should be. Just like individuals in a crowd respecting other people's personal space, the particles work because they get close together, but not too close.
SXC Health Solutions Corp., announces its financial results for the three- and twelve-month periods ended December 31, 2009. Financial references are in U.S. dollars unless otherwise indicated.
Do blood vessels that feed tumors differ from other blood vessels? Fourteen years ago, experiments designed to answer that question led to the discovery of several genes that are more active in tumor-associated blood vessels than in normal blood vessels. New research now reveals the normal function of one of those genes and suggests it could be a good target for anticancer drug therapy.
› Verified 9 days ago
Dr. Derek Gene Kroll, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Medical Center Blvd, Conroe, TX 77304 Phone: 281-719-9681 | |
Dr. Imran Fayaz, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Medical Center Blvd Ste 222, Conroe, TX 77304 Phone: 281-880-0700 Fax: 281-419-9997 | |
Praveen B Reddy, M.D Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1020 Riverwood Ct Ste 305, Conroe, TX 77304 Phone: 832-447-7494 Fax: 832-510-0563 |